Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings Inc. (DE:N6B)
:N6B
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
3.75Last Year’s EPS
3.53Same Quarter Last Year
Strong Buy
Based on 13 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 29, 2025
|% Change Since: 12.12%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong revenue growth, strategic acquisitions, and innovative test launches. However, there were concerns regarding tariff impacts, regulatory changes, and weather-related disruptions affecting margins.Company Guidance
In the Q1 2025 earnings call for Laboratory Corporation of America Holdings, the company reported a solid 5% increase in revenue, with growth in both its Diagnostics Laboratories and Biopharma Laboratory Services (BLS) segments. The Diagnostics segment saw a 6% revenue rise, driven by a recovery from weather impacts earlier in the year, while BLS grew by 3% when adjusted for currency fluctuations. Adjusted earnings per share increased by 4% to $3.84, prompting the company to raise the midpoint of its EPS guidance by $0.05, reflecting an implied growth of approximately 10% for the year. The company maintained its revenue and free cash flow guidance, with expected enterprise revenue growth between 6.7% and 8%. Key strategic moves included partnerships and acquisitions aimed at expanding their market presence in oncology and other high-growth areas, while technological innovations, such as the launch of new consumer-initiated tests and advanced diagnostic tools, are expected to drive future growth. Despite facing macroeconomic challenges like tariff implications, Labcorp emphasized its readiness to manage these impacts through cost efficiencies and operational flexibility.Strong Revenue Growth
Revenue for Q1 2025 was $3.3 billion, up 5.3% compared to last year, driven by organic growth of 2.1% and net acquisitions of 3.7%, partially offset by a foreign currency translation of 0.5%.
Diagnostics Laboratories Business Performance
Diagnostics Laboratories business showed a 6% growth. Adjusted operating income for the quarter was $428 million or 16.3% of revenue.
Biopharma Laboratory Services Segment Growth
Biopharma laboratory services segment grew 3% excluding currency. Margin for BLS was strong, improving 80 basis points, with a quarterly book to bill at 1.13.
New Strategic Collaborations and Acquisitions
Strategic collaborations with Inspira Health and acquisitions of assets from BioReference Health and North Mississippi Health Services were announced, expanding leadership in oncology and other areas.
Innovative Test Launches
Introduced several new tests, including a groundbreaking liquid biopsy test for cancer treatment and a new blood-based biomarker test for Alzheimer's diagnosis.
Adjusted EPS Increase
Adjusted EPS was $3.84, up 4% from last year, with the midpoint of EPS guidance increased by $0.05 per share.
---
DE:N6B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DE:N6B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 29, 2025 | €198.00 | €200.00 | +1.01% |
Feb 06, 2025 | €233.32 | €237.31 | +1.71% |
Oct 24, 2024 | €199.81 | €199.81 | 0.00% |
Aug 01, 2024 | €192.23 | €194.22 | +1.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Labcorp Holdings Inc. (DE:N6B) report earnings?
Labcorp Holdings Inc. (DE:N6B) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Labcorp Holdings Inc. (DE:N6B) earnings time?
Labcorp Holdings Inc. (DE:N6B) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Labcorp Holdings Inc. stock?
The P/E ratio of Labcorp Holdings is N/A.
What is DE:N6B EPS forecast?
DE:N6B EPS forecast for the fiscal quarter 2025 (Q2) is 3.75.
---